Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration

被引:166
作者
Marmorstein, LHY
Munier, FL
Arsenijevic, Y
Schorderet, DF
McLaughlin, PJ
Chung, D
Traboulsi, E
Marmorstein, AD
机构
[1] Cleveland Clin Fdn, Cole Eye Inst, Cleveland, OH 44195 USA
[2] Cleveland Clin Fdn, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44195 USA
[3] CHU Vaudois, Div Med Genet, CH-1004 Lausanne, Switzerland
[4] CHU Vaudois, Hop Ophtalm Jules Gonin, Unite Oculogenet, CH-1004 Lausanne, Switzerland
关键词
D O I
10.1073/pnas.202491599
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Malattia Leventinese (ML), an inherited macular degenerative disease, is closely reminiscent of age-related macular degeneration (AMD), the most common cause of incurable blindness. Both ML and AMD are characterized by extracellular deposits known as drusen between the retinal pigment epithelium (RPE) and Bruch's membrane. The mechanism underlying drusen formation is unknown. An Arg to Trp mutation in a gene of unknown function, EFEMP1, is responsible for ML, indicating EFEMP1 may be important in drusen formation. Here, we show that wild-type EFEMP1 is a secreted protein whereas mutant EFEMP1 is misfolded, secreted inefficiently, and retained within cells. In normal eyes, EFEMP1 is not present at the site of drusen formation. However, in ML eyes, EFEMP1 accumulates within the RPE cells and between the RPE and drusen, but does not appear to be a major component of drusen. Furthermore, in AMD eyes, EFEMP1 is found to accumulate beneath the RPE immediately overlaying drusen, but not in the region where there is no apparent retinal pathology observed. These data present evidence that misfolding and aberrant accumulation of EFEMP1 may cause drusen formation and cellular degeneration and play an important role in the etiology of both ML and AMD.
引用
收藏
页码:13067 / 13072
页数:6
相关论文
共 26 条
[1]   Impairment of the ubiquitin-proteasome system by protein aggregation [J].
Bence, NF ;
Sampat, RM ;
Kopito, RR .
SCIENCE, 2001, 292 (5521) :1552-1555
[2]   AGE-RELATED MACULAR DEGENERATION [J].
BRESSLER, NM ;
BRESSLER, SB ;
FINE, SL .
SURVEY OF OPHTHALMOLOGY, 1988, 32 (06) :375-413
[3]  
Collins T., 1913, OPHTHALMOSCOPE, V11, P537
[4]  
Doyne RW., 1899, T OPHTHAL SOC UK, V19, P71
[5]   Risk factors for age-related macular degeneration [J].
Evans, JR .
PROGRESS IN RETINAL AND EYE RESEARCH, 2001, 20 (02) :227-253
[6]   Assessment of the phenotypic range seen in Doyne honeycomb retinal dystrophy [J].
Evans, K ;
Gregory, CY ;
Wijesuriya, SD ;
Kermani, S ;
Jay, MR ;
Plant, C ;
Bird, AC .
ARCHIVES OF OPHTHALMOLOGY, 1997, 115 (07) :904-910
[7]   Drug therapy: Age-related macular degeneration. [J].
Fine, SL ;
Berger, JW ;
Maguire, MG ;
Ho, AC .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (07) :483-492
[8]   PROTEIN DISULFIDE ISOMERASE - MULTIPLE ROLES IN THE MODIFICATION OF NASCENT SECRETORY PROTEINS [J].
FREEDMAN, RB .
CELL, 1989, 57 (07) :1069-1072
[9]   Role of Hsp70 in regulation of stress-kinase JNK: implications in apoptosis and aging [J].
Gabai, VL ;
Meriin, AB ;
Yaglom, JA ;
Volloch, VZ ;
Sherman, MY .
FEBS LETTERS, 1998, 438 (1-2) :1-4
[10]  
GERBER D, 2002, IN PRESS INVEST OPHT